Poulvac Maternavac 4 (Canada)This page contains information on Poulvac Maternavac 4 for veterinary use.
The information provided typically includes the following:
- Poulvac Maternavac 4 Indications
- Warnings and cautions for Poulvac Maternavac 4
- Direction and dosage information for Poulvac Maternavac 4
Poulvac Maternavac 4This treatment applies to the following species:
Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Vaccine
Standard & Variant, Massachusetts Type, Killed Virus
This product has been shown to be effective for the vaccination of healthy primed chickens between 16 and 22 weeks of age against standard and variant infectious bursal disease, Newcastle disease, infectious bronchitis Mass type, and malabsorption due to reovirus. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
The vaccine has been shown to be effective in progeny of vaccinates against standard and variant infectious bursal disease, Newcastle disease, and malabsorption due to reovirus.
Directions For Use
Inject 0.5 mL intramuscularly or subcutaneously using aseptic technique. Vaccinate only healthy birds. For primed birds, a single dose between 16 and 22 weeks (approximately 4 weeks prior to lay) is indicated.
PrecautionsStore in the dark at 2°-8°C (35°-46°F). Do not freeze. Warm to 22°-32°C and shake well before using. Use entire contents when first opened. Do not vaccinate within 42 days before slaughter. Contains gentamicin and amphotericin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (800) 461-0917.
For veterinary use only
U.S. Veterinary License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
Copyright © 2023 Animalytix LLC. Updated: 2023-02-28